肾癌患者的淋巴结清扫术：何时需要进行？
Lymph node dissection in patients with kidney cancer: when is it indicated?
作者信息
Palapattu Ganesh S, Kim Hyung L, Belldegrun Arie S
出版信息
Rev Urol. 2003 Summer;5(3):196-9.
Abstract
It is necessary to consider the potential risks and benefits of performing a lymph node dissection (LND) at the time of radical nephrectomy. LND may lead to more accurate staging, a decrease in local recurrence, and an increase in survival for patients with metastatic disease limited to the resected lymph nodes. However, there are risks associated with the treatment that must be considered. The advantages of LND vary among patients, depending on the location and extent of disease progression. For patients with stage T3 or T4 disease, we recommend a limited LND. Patients with T3 or T4 disease with grossly positive nodes with or without hematogenous metastasis should undergo a more extensive LND.
摘要
在根治性肾切除术时，有必要考虑进行淋巴结清扫术（LND）的潜在风险和益处。对于转移性疾病局限于切除淋巴结的患者，LND可能会带来更准确的分期、局部复发率降低以及生存率提高。然而，必须考虑该治疗所伴随的风险。LND的优势因患者而异，取决于疾病进展的部位和程度。对于T3或T4期疾病的患者，我们建议进行有限的LND。伴有或不伴有血行转移且淋巴结明显阳性的T3或T4期疾病患者应接受更广泛的LND。
相似文献
1
Lymph node dissection in patients with kidney cancer: when is it indicated?肾癌患者的淋巴结清扫术：何时需要进行？
Rev Urol. 2003 Summer;5(3):196-9.
2
Lymph node dissection in renal cell carcinoma.肾细胞癌的淋巴结清扫术。
Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13.
3
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.腹膜后淋巴结清扫术（RPLND）是否可用于延长局限性淋巴结受累的肾细胞癌（RCC）患者的生存时间？复发模式分析。
Urol Oncol. 2022 Nov;40(11):495.e11-495.e17. doi: 10.1016/j.urolonc.2022.08.006. Epub 2022 Sep 22.
4
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT non-metastatic renal cell carcinoma treated with radical nephrectomy.淋巴结清扫和阳性淋巴结对接受根治性肾切除术治疗的当代pT期非转移性肾细胞癌患者癌症特异性死亡率的影响。
BJU Int. 2018 Mar;121(3):383-392. doi: 10.1111/bju.14024. Epub 2017 Oct 12.
5
Lymph Nodes Dissection in Elderly Patients with T3-T4 Laryngeal Cancer.老年 T3-T4 声门型喉癌患者行淋巴结清扫术。
Clin Interv Aging. 2020 Dec 8;15:2321-2330. doi: 10.2147/CIA.S283600. eCollection 2020.
6
Lymph node dissection in bladder cancer. Impact on staging and prognosis.膀胱癌的淋巴结清扫术。对分期和预后的影响。
Dan Med J. 2012 Dec;59(12):B4559.
7
Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?在术前影像学检查未发现可疑淋巴结转移的上尿路尿路上皮癌患者中，肾输尿管切除术期间进行淋巴结清扫是否会影响肿瘤学结局？
World J Urol. 2017 Apr;35(4):665-673. doi: 10.1007/s00345-016-1918-z. Epub 2016 Aug 8.
8
Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.在肾细胞癌中，淋巴结分期必须扩大：敏感性曲线分析。
BJU Int. 2013 Mar;111(3):412-8. doi: 10.1111/j.1464-410X.2012.11313.x. Epub 2012 Jun 15.
9
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.根治性膀胱切除术治疗膀胱癌患者的广泛淋巴结清扫与局限性淋巴结清扫的比较：一项前瞻性随机试验的生存结果。
Eur Urol. 2019 Apr;75(4):604-611. doi: 10.1016/j.eururo.2018.09.047. Epub 2018 Oct 15.
10
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.根治性肾切除术联合或不联合淋巴结清扫术治疗非转移性肾细胞癌：基于倾向评分的分析。
Eur Urol. 2017 Apr;71(4):560-567. doi: 10.1016/j.eururo.2016.09.019. Epub 2016 Sep 24.
引用本文的文献
1
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.晚期和转移性肾细胞癌的外科治疗：多学科方法
Front Oncol. 2017 May 31;7:107. doi: 10.3389/fonc.2017.00107. eCollection 2017.
本文引用的文献
1
Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.伴有腹膜后淋巴结转移的肾细胞癌：淋巴结清扫术的作用
J Urol. 2003 Jun;169(6):2076-83. doi: 10.1097/01.ju.0000066130.27119.1c.
2
The number of lymph nodes examined and staging accuracy in renal cell carcinoma.肾细胞癌中检查的淋巴结数量与分期准确性
BJU Int. 2003 Jan;91(1):37-40. doi: 10.1046/j.1464-410x.2003.04017.x.
3
Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.转移灶的数量而非位置决定了淋巴结阴性转移性肾细胞癌患者的总生存期。
Urology. 2003 Feb;61(2):314-9. doi: 10.1016/s0090-4295(02)02163-5.
4
Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?区域淋巴结清扫术在肾细胞癌治疗中的应用：对于术前或术中无可疑淋巴结肿大的患者是否有用？
BJU Int. 2001 Aug;88(3):169-72. doi: 10.1046/j.1464-410x.2001.02315.x.
5
Improved prognostication of renal cell carcinoma using an integrated staging system.
J Clin Oncol. 2001 Mar 15;19(6):1649-57. doi: 10.1200/JCO.2001.19.6.1649.
6
Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group.
Eur Urol. 1999 Dec;36(6):570-5. doi: 10.1159/000020050.
7
Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.肾细胞癌中的淋巴结受累情况及系统性淋巴结清扫术对生存机会的影响
Anticancer Res. 1999 Mar-Apr;19(2C):1573-8.
8
Role of lymphadenectomy in the treatment of renal cell carcinoma.淋巴结清扫术在肾细胞癌治疗中的作用。
Urology. 1993 Jan;41(1):9-15. doi: 10.1016/0090-4295(93)90234-2.
9
The role of lymphadenectomy in the management of renal cell carcinoma.淋巴结清扫术在肾细胞癌治疗中的作用。
Urol Clin North Am. 1980 Oct;7(3):705-9.
10
Lymphadenectomy in renal adenocarcinoma.
J Urol. 1982 Jun;127(6):1090-1. doi: 10.1016/s0022-5347(17)54242-1.
Zotero 插件